US Patent 11180758 Antiviral proteins and their uses in therapeutic methods
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+462 characters)
Article
Patent abstract
Three proteins, BCL-G (BCL2L14), CMPK2, and LAMP3, were discovered to independently restrict HIV-1 replication both in-vivo and in-vitro. Methods are described wherein subjects are given an effective amount of a pharmaceutical composition comprising a protein selected from the group consisting of BCL-G, CMPK2, LAMP3, functional parts thereof, recombinant proteins thereof, and combinations thereof, for the purpose of treating or preventing HIV.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
111807580
Date of Patent
November 23, 2021
0Patent Application Number
160787600
Date Filed
February 24, 2017
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
111807580
Date of Patent
November 23, 2021
0Patent Application Number
160787600
Date Filed
February 24, 2017
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 11180758 Antiviral proteins and their uses in therapeutic methods
Infobox
Is a
Patent jurisdiction
Patent number
11180758
Date of patent
November 23, 2021
Patent application number
16078760
Date Filed
February 24, 2017
Patent primary examiner
Find more entities like US Patent 11180758 Antiviral proteins and their uses in therapeutic methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
